Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 136

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 136
---

                                            Share  
    Weighted
                                                                                Average
                                            Remaining Life
                                                                                (Years) 
  
    Outstanding
    as of December 31, 2024 
     1,359,375  
    $0.80  
     0.93 
  
    Exercised 
     (1,359,375) 
     0.80  
     - 
  
    Forfeited 
     -  
     -  
     - 
  
    Outstanding
    as of September 30, 2025 
     -  
    $-  
     - 

    18

JUPITER
NEUROSCIENCES, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note
6 – Stockholders’ Equity, continued

Effective
June 22, 2025, the Company entered into an amendment with a warrant holder for a warrant to purchase 109,376 shares of Common Stock.
The amendment extended the warrant’s exercise period through August 31, 2025, and clarified the exercise mechanism applicable to
the warrant. The effects of the warrant modification were de minimis.

On
July 16, 2025 the Company entered into an amendment with a warrant holder who holds 1,249,999
warrants that clarified the exercise mechanisms. Concurrently with the amendment, the warrant holder exercised the warrants via a
cashless exercise and received 913,299
shares of Common Stock. Pursuant to the amendment, the Company agreed to issue the warrant holder 86,700
shares of Common Stock.

On
August 12, 2025, the Company received an exercise notice from a warrant holder who holds 109,376 warrants. The warrant was exercised
via a cashless exercise, and the warrant holder received 30,547 shares of Common Stock. Pursuant to the amended warrant agreement, the
Company agreed to issue the warrant holder 56,954 shares of Common Stock.

Restricted
Stock Units

Certain
shares previously presented as issued and outstanding in connection with vested restricted stock units were not legally issued due to
administrative delays and, accordingly, were removed from shares outstanding as of September 30, 2025. The correction reduced shares
outstanding from 34,833,083 at June 30, 2025 to 34,294,546 at September 30, 2025, a decrease of